The Difficulty of Diagnosing Anorexia in the GLP-1 Era
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"The Difficulty of Diagnosing Anorexia in the GLP-1 Era" is generating significant coverage in the Health category, with 4 articles from 3 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Meteo.gr, Latin Times and The New York Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 28d ago.
Quick answers
Why is "The Difficulty of Diagnosing Anorexia in the GLP-1 Era" trending?
Because 3 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (4)
- weight loss drugs are driving a new eating disorder Meteo.gr · 30d ago
- GLP-1 Drugs and Anorexia: How Telehealth Loopholes Are Endangering the Most Vulnerable Patients Latin Times · 30d ago
- The Difficulty of Diagnosing Anorexia in the GLP-1 Era The New York Times · 30d ago
- weight loss drugs are driving a new eating disorder Meteo.gr · 31d ago
Topics
Related trends
Taking GLP-1s forever? 5 strategies to keep weight off if you stop
New research outlines five evidence-based strategies to maintain weight loss after discontinuing GLP-1 medications like semaglutide and tirzepatide.
Hundreds of children in England prescribed weight-loss jabs, figures show
Recent figures reveal hundreds of children in England are receiving GLP-1 weight-loss prescriptions.
Makers of obesity drugs hit back at claims of negative side effects
Makers of blockbuster weight loss drugs defend product safety amid mounting scrutiny over potential side effects.
The Offshore Wind Industry Gave Him the Well-Paying Work He Needed. Then Trump Gutted It.
Offshore wind industry faces uncertainty after Trump's actions
The Fed chief said AI would tame inflation. His colleagues disagree.
Federal Reserve officials are publicly divided over whether artificial intelligence infrastructure is driving or taming inflation.
DJ Khaled reflects on using GLP-1s in 90-pound weight loss journey: ‘I needed help’
DJ Khaled publicly details a 75-to-90-pound weight loss aided by GLP-1 medication Wegovy, sparking wide entertainment-media coverage.